Market Sentiment for BIIB

Live Market Sentiment

Negative (-0.2360)

(Latest daily score)

Predicted Return

18.80%

7-day sentiment average

Advisory Opinion

Buy

Derived from sentiment trend

News Items (period)

1,295

The table below gives each of the most recent headlines of the stock and the negative, neutral, positive aggregated sentiment score.

Date	Headline	Source	Sentiment
2026-04-04	Biogen’s Apellis Deal Reshapes Growth Outlook And Valuation Story	Simply Wall St.	Strong Positive (0.7337)
2026-04-03	Where the New Houses Are—and What That Says About Growth	Barrons.com	Neutral (0.0006)
2026-04-03	1 Cash-Producing Stock for Long-Term Investors and 2 We Turn Down	StockStory	Neutral (-0.0004)
2026-04-03	Hims & Hers Health, Regeneron, Biogen, BioMarin Pharmaceutical, and Moderna Shares Are Falling, What You Need To Know	StockStory	Strong Negative (-0.5704)
2026-04-02	Royalty Pharma, Johnson & Johnson Strike $500M Autoimmune Drug Deal	Insider Monkey	Positive (0.1357)
2026-04-01	Biogen, on the heels of a $5.6B buyout, turns its sights to early-stage assets	BioPharma Dive	Positive (0.3889)
2026-04-01	SRRK Stock Jumps on Resubmission of FDA Filing for SMA Drug	Zacks	Negative (-0.3648)
2026-04-01	Biogen to Acquire Apellis for $5.6B to Strengthen Immunology Portfolio	Zacks	Strong Positive (0.8844)
2026-04-01	LLY to Buy Neuroscience Biotech Centessa Pharmaceuticals in $7.8B Deal	Zacks	Neutral (0.0798)
2026-04-01	Disney upgraded, Nike downgraded: Wall Street's top analyst calls	The Fly	Negative (-0.3920)